To explore the role of CDC5L in GC, we conducted in vitro and in vivo assays, alongside molecular mechanism studies using luciferase reporter assays, co-immunoprecipitation (CO-IP), and mass spectrometry (MS). This evidence concerns the gene CDC5L and gastric cancer.